| Hans-Günter Meyer-Thompson | Gabapentinoide
Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population.
Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population.
Peckham AM, Fairman KA, Sclar DA.
Clin Drug Investig. 2017 Apr 27. doi: 10.1007/s40261-017-0530-3.
Abstract